This is an open question for those of you who seem to speak with Mr. Marshall on a regular basis: does he consider all of the applications discussed on this board in valuing the company (bed bugs included) or is he focussed completely on AS and the bioterrorism stuff? I ask this because I hope that current shareholders are well compensated in the event of a buyout (which people keep mentioning on this board). I'd like to hear your impressions. TIA, Lep.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.